Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,284,639
+$5,161,748 QoQ
Shares Held
260,990
+552.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#532
of 2,821 holders
Holding Since
Sep 2020
16 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Dec 31, 2025CallValue
$2,490,000
CallShares
100,000
PutValue
$12,450,000
PutShares
500,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LMR Partners LLP holds $144,798,606 across 13 Drug Manufacturers - General names. PFE ranks #5 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GSK |
GSK plc
|
980,479 | $51,396,709 | |
| 2 | NVS |
Novartis AG
|
153,726 | $24,091,938 | |
| 3 | ABBV |
AbbVie Inc.
|
79,736 | $20,064,766 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
330,151 | $19,023,300 | |
| 5 | PFE |
Pfizer Inc
This page
|
260,990 | $6,284,639 | |
| 6 | MRK |
Merck & Co., Inc.
|
44,030 | $5,657,855 | |
| 7 | OGN |
Organon & Co.
|
396,842 | $5,373,240 | |
| 8 | LLY |
ELI LILLY & Co
|
3,390 | $4,066,066 |
All Filings in PFE
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,284,639 | 260,990 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $1,122,891 | 39,989 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $2,490,000 | 100,000 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $12,450,000 | 500,000 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $12,613,119 | 506,551 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $12,775,672 | 501,400 | Shares | Other | 2025-11-14 | |
| 2025-09-30 | $12,740,000 | 500,000 | Put | Sole | 2025-11-14 | |
| 2025-06-30 | $12,120,000 | 500,000 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $12,120,000 | 500,000 | Put | Sole | 2025-08-14 | |
| 2025-03-31 | $12,670,000 | 500,000 | Put | Sole | 2025-05-15 | |
| 2025-03-31 | $15,063,792 | 594,467 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $13,265,000 | 500,000 | Put | Sole | 2025-02-14 | |
| 2024-12-31 | $16,872,894 | 635,993 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $2,995,237 | 112,900 | Call | Sole | 2025-02-14 | |
| 2024-09-30 | $11,193,992 | 386,800 | Call | Sole | 2024-11-07 | |
| 2024-09-30 | $3,617,500 | 125,000 | Put | Sole | 2024-11-07 | |
| 2024-09-30 | $65,606 | 2,267 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $3,128,164 | 111,800 | Call | Other | 2024-08-14 | |
| 2023-12-31 | $13,675,250 | 475,000 | Call | Sole | 2024-02-14 | |
| 2023-09-30 | $9,251,113 | 278,900 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $16,528,611 | 498,300 | Put | Sole | 2023-11-14 | |
| 2023-06-30 | $20,111,644 | 548,300 | Put | Sole | 2023-08-14 | |
| 2023-06-30 | $3,668,000 | 100,000 | Call | Sole | 2023-08-14 | |
| 2022-03-31 | $63,526,967 | 1,227,100 | Put | Sole | 2022-05-16 | |
| 2021-12-31 | $8,025,721 | 135,914 | Shares | Sole | 2022-02-14 | |
| 2021-03-31 | $2,251,404 | 62,142 | Shares | Sole | 2021-05-17 | |
| 2020-09-30 | $249,156 | 6,789 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||